Nebraska's ERS Real Estate Group Brings $170M in Production and Big Vision to eXp Realty ERS juggernaut joins eXp Realty with plans to reshape the real estate experience through its Elite Real Estate Systems LLP — Neutral
EXPI GlobeNewsWire — May 20, 2025BELLINGHAM, Wash., May 20, 2025 (GLOBE NEWSWIRE) -- eXp Realty®, “the most agent-centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced the addition of ERS Real Estate Group, the residential arm of Omaha-based Elite Real Estate Systems LLP (ERS). Co-founders Jeff Cohn and Renee Mueller are leaders of the 53 agents who closed $170 million in sales volume across 575 units in 2024.

Compass Group Diversified Holdings (CODI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
CODI PRNewsWire — May 20, 2025BENSALEM, Pa. , May 20, 2025 /PRNewswire/ -- The Law Offices of Howard G.

West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
WST PRNewsWire — May 20, 2025BENSALEM, Pa. , May 20, 2025 /PRNewswire/ -- The Law Offices of Howard G.

Manhattan Associates Unveils Agentic AI Innovation at Momentum 2025 — Neutral
MANH Business Wire — May 20, 2025LAS VEGAS--(BUSINESS WIRE)--Manhattan has announced sweeping Agentic AI support within Manhattan Active® solutions that includes intelligent, autonomous digital agents.

Deadline Approaching: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith — Neutral
IOVA Business Wire — May 20, 2025BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 14, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN IOVANCE BIOTHERAPEUTICS, INC. (IOVA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIP.

Manhattan Associates Launches Supply Chain Commerce Solutions on Google Cloud Marketplace — Neutral
MANH Business Wire — May 20, 2025LAS VEGAS--(BUSINESS WIRE)--Manhattan today announced an expanded GTM partnership with Google Cloud, enabling customers to accelerate their digital transformation success.

Digimarc Corporation (DMRC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
DMRC PRNewsWire — May 20, 2025LOS ANGELES , May 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Digimarc Corporation ("Digimarc" or the "Company") (NASDAQ: DMRC) have opportunity to lead the securities fraud class action lawsuit.

ECB highlights gold's increasing risks, analysts say threat is overstated — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — May 20, 2025Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

SHOP Surges 34% in a Month: Should You Buy the Stock Now or Wait? — Positive
SHOP Zacks Investment Research — May 20, 2025Shopify shares benefit from strong merchant growth and AI tools, but stretched valuation and fierce competition remain a concern.

Transaction in Own Shares 20 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 20 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 20/05/2025 511,994 £24.9350 £24.6700 £24.8005 LSE GBP 20/05/2025 141,516 £24.9400 £24.6700 £24.8060 Chi-X (CXE) GBP 20/05/2025 78,490 £24.9400 £24.6750 £24.8024 BATS (BXE) GBP 20/05/2025 456,063 €29.7700 €29.4750 …

Baidu Gears Up to Post Q1 Earnings: Buy, Sell or Hold the Stock? — Positive
BIDU Zacks Investment Research — May 20, 2025Baidu, Inc. BIDU is scheduled to report first-quarter 2025 results on May 21, before the opening bell. In the last reported quarter, Baidu reported non-GAAP earnings per share (EPS) of $2.63, which significantly beat the Zacks Consensus Estimate of $1.78.

Buy, Hold or Sell Deckers Stock? Key Tips Ahead of Q4 Earnings — Negative
DECK Zacks Investment Research — May 20, 2025Can Deckers' brand power and DTC strength outweigh margin pressures, or will headwinds stall its momentum? Find out before Q4 earnings drop.

Here's Why Investors Should Give Knight-Swift Stock a Miss Now — Negative
KNX Zacks Investment Research — May 20, 2025KNX is hurt by escalated operating expenses related to driver wages, equipment, maintenance, and other expenses.

Top Fund Managers Are Buying These 3 Cheap Stocks — Positive
ADBE GIS STZ Morningstar — May 20, 2025Buffett expects to own some stocks indefinitely—and one of those stocks looks cheap today.

Pfizer Inc. decided to think bigger after the Summit deal in February and that it needs control of a PD-1/VEGF bispecific antibody versus participating with its ADC pipeline. The 3SBio deal allows increased control of its oncology pipeline and much higher financial rewards in the long run, and comes at a relatively low cost. The jury is still out on the PD-1/VEGF bispecific antibody class of drugs, but the data to date make this approach worth exploring, and perhaps even necessary.

Leading Economic Indicator Drops in April — Positive
HD PANW TOL VIK Zacks Investment Research — May 20, 2025Leading Economic Indicator Drops in April.

Radian Group continues to outperform, driven by strong Q1 results, robust capital returns, and minimal exposure to tariffs or housing market volatility. Solid credit metrics, high home prices, and disciplined reserve management support my view that Radian's risk profile remains low despite a gradual earnings normalization. Accelerated capital releases and regulatory tailwinds enable higher-than-expected buybacks and dividends, boosting shareholder returns and reducing share count significantly.

Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA) - Contact Levi & Korsinsky Before July 14, 2025 — Neutral
IOVA Accesswire — May 20, 2025NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=149414&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

MADISON, Wis.--(BUSINESS WIRE)--MGE Energy Declares Regular Dividend.

Healy: Homebuilders Continue to Build on Strong Foundation — Positive
ITB LEN PHM TOL Schwab Network — May 20, 2025"Everyone still needs a place to live," says Rogers Healy. He argues homebuilders companies have and will continue to experience plenty of strength heading into the rest of the year.
